BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23262664)

  • 21. Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro.
    Templin AT; Mellati M; Meier DT; Esser N; Hogan MF; Castillo JJ; Akter R; Raleigh DP; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2020 Nov; 63(11):2385-2395. PubMed ID: 32728889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
    Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
    J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice.
    Castillo JJ; Aplin AC; Hackney DJ; Hogan MF; Esser N; Templin AT; Akter R; Kahn SE; Raleigh DP; Zraika S; Hull RL
    Diabetologia; 2022 Oct; 65(10):1687-1700. PubMed ID: 35871651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
    Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
    Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
    PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory properties of exenatide in human pancreatic islets.
    Cechin SR; Pérez-Álvarez I; Fenjves E; Molano RD; Pileggi A; Berggren PO; Ricordi C; Pastori RL
    Cell Transplant; 2012; 21(4):633-48. PubMed ID: 21669040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.
    Li L; El-Kholy W; Rhodes CJ; Brubaker PL
    Diabetologia; 2005 Jul; 48(7):1339-49. PubMed ID: 15902400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.
    Doliba NM; Qin W; Najafi H; Liu C; Buettger CW; Sotiris J; Collins HW; Li C; Stanley CA; Wilson DF; Grimsby J; Sarabu R; Naji A; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E87-E102. PubMed ID: 21952036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
    Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
    Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A GLP‑1 receptor agonist attenuates human islet amyloid polypeptide‑induced autophagy and apoptosis in MIN6 cells.
    Chen X; Huang T; Shi Y; Wang L; Li W; Shen F; Gu X
    Mol Med Rep; 2019 Feb; 19(2):1365-1371. PubMed ID: 30569165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS; Ahrén B
    J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death.
    Marzban L; Rhodes CJ; Steiner DF; Haataja L; Halban PA; Verchere CB
    Diabetes; 2006 Aug; 55(8):2192-201. PubMed ID: 16873681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
    Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
    Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
    Koska J; Sands M; Burciu C; D'Souza KM; Raravikar K; Liu J; Truran S; Franco DA; Schwartz EA; Schwenke DC; D'Alessio D; Migrino RQ; Reaven PD
    Diabetes; 2015 Jul; 64(7):2624-35. PubMed ID: 25720388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
    Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
    Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans.
    de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A
    Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.
    Chen YC; Mains RE; Eipper BA; Hoffman BG; Czyzyk TA; Pintar JE; Verchere CB
    Diabetologia; 2020 Mar; 63(3):561-576. PubMed ID: 31984442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture.
    Marzban L; Tomas A; Becker TC; Rosenberg L; Oberholzer J; Fraser PE; Halban PA; Verchere CB
    Diabetes; 2008 Nov; 57(11):3045-55. PubMed ID: 18694973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus.
    Caillon L; Hoffmann AR; Botz A; Khemtemourian L
    J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.